JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Khalil Fattouch
Emiliano Navarra
Giovanni Ruvolo
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fattouch, K.
Right arrow Articles by Ruvolo, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fattouch, K.
Right arrow Articles by Ruvolo, G.
Related Collections
Right arrow Coronary disease
Right arrow Valve disease

J Thorac Cardiovasc Surg 2009;138:278-285
© 2009 The American Association for Thoracic Surgery


Point/Counterpoint

POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: A randomized trial

Khalil Fattouch, MD, PhD*, Francesco Guccione, MD, Roberta Sampognaro, MD, Gaetano Panzarella, MD, Egle Corrado, MD, Emiliano Navarra, MD, Davide Calvaruso, MD, Giovanni Ruvolo, MD

Department of Cardiac Surgery, University of Palermo, Palermo, Italy

Received for publication May 2, 2008; revisions received September 29, 2008; accepted for publication November 7, 2008.

* Address for reprints: Khalil Fattouch, MD, PhD, University of Palermo, Department of Cardiac Surgery, Via Liborio Giuffré, 5, 90127 Palermo, Italy. (Email: khalilfattouch{at}hotmail.com).

Objective: Surgical management of moderate chronic ischemic mitral valve regurgitation is still debated. The aim of this study was to evaluate the effect of adding mitral valve repair to coronary artery bypass grafting on clinical outcomes and left ventricular remodeling in patients who underwent coronary artery bypass grafting alone versus coronary artery bypass grafting plus mitral valve repair in a randomized trial.

Methods: Between February 2003 and May 2007, 102 patients were eligible for this study and were randomly assigned to one of 2 groups by means of card allocation: coronary artery bypass grafting plus mitral valve repair (CABG plus MVR group; 48 patients, 47%) or coronary artery bypass grafting alone (CABG group; 54 patients, 53%). The 2 groups were similar regarding demographics, perioperative clinical data, and outcomes. There were differences regarding cardiopulmonary bypass (P < .0001) and aortic crossclamp (P < .0001) times. Exercise tests were performed for all survivors to evaluate tolerance to exercise and variability on grade of mitral regurgitation and systolic pulmonary arterial pressure. The study was blinded for physicians and nurses involved in postoperative care and clinical follow-up. The mean follow-up was 32 ± 18 months.

Results: Overall in-hospital mortality was 3% (3 patients). One (1.8%) patient died in the CABG group, and 2 (4.1%) patients died in the CABG plus MVR group. Survival rates ± standard error at 5 years for patients in the CABG and CABG plus MVR groups were 88.8% ± 3.2% and 93.7% ± 3.1%, respectively. A significant difference was found between the 2 groups with regard to mean New York Heart Association class (P < .0001), left ventricular end-diastolic diameter (P < .01), left ventricular end-systolic diameter (P < .01), pulmonary arterial pressure (P < .0001), and left atrial size (P < .01). At follow-up, coronary artery bypass grafting alone was able to reduce mitral regurgitation grade in 40% of patients, whereas in the remaining patients mitral regurgitation grade remained stable or worsened. In the CABG group, among the 17 patients with mild mitral regurgitation and 12 patients with moderate mitral regurgitation at rest, 7 (40%) and 9 (75%) patients, respectively, had worsening in mitral regurgitation grade and pulmonary artery pressure during exercise.

Conclusions: The efficacy of adding mitral valve repair to coronary artery bypass grafting is well demonstrated by the improvement of New York Heart Association functional class and percentage of left ventricular ejection fraction and by the decrease of mitral regurgitation grade, left ventricular end-diastolic diameter, left ventricular end-systolic diameter, pulmonary artery pressure, and left atrial size. Moreover, coronary artery bypass grafting alone left more patients with heart failure symptoms at rest and during exercise. Combined coronary artery bypass grafting and mitral valve repair have no effect on survival at short-term follow-up, and the trends that are evident will likely become more significant with time.



Abbreviations and Acronyms CABG = coronary artery bypass grafting; cIMR = chronic ischemic mitral regurgitation; CPB = cardiopulmonary bypass; IMR = ischemic mitral regurgitation; LVEDD = left ventricular end-diastolic diameter; LVEF = left ventricular ejection fraction; LVESD = left ventricular end-systolic diameter; MR = mitral regurgitation; MVR = mitral valve repair; NYHA = New York Heart Association; PAP = pulmonary artery pressure; TEE = transesophageal echocardiography; TTE = transthoracic echocardiography





This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al.
2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
J. Thorac. Cardiovasc. Surg., January 1, 2012; 143(1): 4 - 34.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. K. Smith, R. E. Michler, Y. J. Woo, J. H. Alexander, J. D. Puskas, M. K. Parides, R. T. Hahn, J. B. Williams, J. M. Dent, T. B. Ferguson Jr., et al.
Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical Trials Network
J. Thorac. Cardiovasc. Surg., January 1, 2012; 143(1): 111 - 117.e1.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al.
Special Article: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Anesth. Analg., January 1, 2012; 114(1): 11 - 45.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., December 6, 2011; 58(24): 2584 - 2614.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., December 6, 2011; 58(24): e123 - e210.
[Full Text] [PDF]


Home page
CirculationHome page
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation, December 6, 2011; 124(23): e652 - e735.
[Full Text] [PDF]


Home page
CirculationHome page
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al.
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Circulation, December 6, 2011; 124(23): 2610 - 2642.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Kainuma, K. Taniguchi, K. Toda, T. Funatsu, H. Kondoh, M. Nishino, T. Daimon, and Y. Sawa
Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation
J. Thorac. Cardiovasc. Surg., October 1, 2011; 142(4): 783 - 792.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. A. Acker, M. Jessup, S. F. Bolling, J. Oh, R. C. Starling, D. L. Mann, H. N. Sabbah, R. Shemin, J. Kirklin, and S. H. Kubo
Mitral valve repair in heart failure: Five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial
J. Thorac. Cardiovasc. Surg., September 1, 2011; 142(3): 569 - 574.e1.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. M. Calafiore, A. L. Iaco, A. Bivona, E. Varone, S. Scandura, P. Greco, A. Romeo, and M. Di Mauro
Echocardiographically based treatment of chronic ischemic mitral regurgitation
J. Thorac. Cardiovasc. Surg., May 1, 2011; 141(5): 1150 - 1156.e1.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. A. Pierard and B. A. Carabello
Ischaemic mitral regurgitation: pathophysiology, outcomes and the conundrum of treatment
Eur. Heart J., December 2, 2010; 31(24): 2996 - 3005.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. A. ten Brinke, R. J. Klautz, S. A. Tulner, H. F. Verwey, J. J. Bax, V. Delgado, E. R. Holman, M. J. Schalij, E. E. van der Wall, J. Braun, et al.
Clinical and Functional Effects of Restrictive Mitral Annuloplasty at Midterm Follow-Up in Heart Failure Patients
Ann. Thorac. Surg., December 1, 2010; 90(6): 1913 - 1920.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. D. Glower
Invited Commentary
Ann. Thorac. Surg., December 1, 2010; 90(6): 1920 - 1921.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. A. ten Brinke, R. J. Klautz, S. A. Tulner, H. F. Verwey, J. J. Bax, M. J. Schalij, E. E. van der Wall, M. I. Versteegh, R. A. Dion, and P. Steendijk
Long-term effects of surgical ventricular restoration with additional restrictive mitral annuloplasty and/or coronary artery bypass grafting on left ventricular function: Six-month follow-up by pressure-volume loops
J. Thorac. Cardiovasc. Surg., December 1, 2010; 140(6): 1338 - 1344.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Fattouch, R. Sampognaro, G. Speziale, M. Salardino, G. Novo, M. Caruso, S. Novo, and G. Ruvolo
Impact of Moderate Ischemic Mitral Regurgitation After Isolated Coronary Artery Bypass Grafting
Ann. Thorac. Surg., October 1, 2010; 90(4): 1187 - 1194.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Pocar, D. Passolunghi, A. Moneta, A. Di Mauro, A. Bregasi, R. Mattioli, and F. Donatelli
Baseline left ventricular function and surgical annular stiffening to predict outcome and reverse left ventricular remodeling after undersized annuloplasty for intermediate-degree ischemic mitral regurgitation
J. Thorac. Cardiovasc. Surg., June 1, 2010; 139(6): 1529 - 1538.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
M. Pocar, A. Di Mauro, D. Passolunghi, A. Moneta, A. M. T. A. Alsheraei, A. Bregasi, R. Mattioli, and F. Donatelli
Predictors of adverse events after surgical ventricular restoration for advanced ischaemic cardiomyopathy
Eur J Cardiothorac Surg, May 1, 2010; 37(5): 1093 - 1100.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. J. Gardner and P. T. O'Gara
The Cardiothoracic Surgery Network: Randomized clinical trials in the operating room.
J. Thorac. Cardiovasc. Surg., April 1, 2010; 139(4): 830 - 834.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.